multiomics for lnp-mrna oncology programs

Turning biodistribution into biological insights.

We turn complex molecular data into clear, actionable insights — giving your team the confidence to advance LNP–mRNA programs faster, smarter, and with molecular patterns that drive outcomes and tell a compelling, evidence-rich story for your stakeholders.

allumiqs advantage

Transform your LNP-mRNA studies.

Lipid Nanoparticle (LNP)–mRNA therapeutics are accelerating in oncology. Imaging shows where your therapy goes. Multiomics reveals what the therapy is doing, biologically — enabling mechanistic understanding, biomarker discovery, and translational confidence. Allumiqs delivers integrated, high‑resolution molecular profiling that transforms your LNP–mRNA studies from descriptive to mechanistic-driven and development‑ready.

Let’s Connect

Why does multiomics matter?

Route of administration dictates biology.

Different delivery routes — IV, intratumoral, intrathecal, localized — drive distinct biological outcomes:

Tissue exposure and cellular uptake
mRNA expression profiles
Immune activation and safety signatures

Multiomics captures these differences with molecular precision, enabling smarter formulation, dosing and delivery decisions.

Proteomics & Transcriptomics

Moving beyond biodistribution to function.

Key questions for every LNP-mRNA program:

Is the mRNA translated?
Are intended pathways engaged?
Is there a measurable pharmacodynamic response?

Allumiqs’ proteomics and transcriptomics solutions provide molecular evidence of functional delivery and downstream pathway modulation.

Accelerating LNP-mRNA Programs

Optimized Delivery and Formulation Strategies

Compare biological outcomes across routes, doses, and formulations
Inform study design and development decisions

Functional Biological Response Assessments

Molecular signatures of target engagement
Pathway modulation and therapeutic activity

Immune and Safety Signal Profiling

Cytokines and inflammatory responses (serum/plasma)
Tumor microenvironment remodeling
Off‑target responses in liver, spleen, and other key organs

Biomarker and Response Stratification

Identify responders vs non‑responders
Resistance mechanisms
Translational biomarkers linked to imaging and phenotypic endpoints

Translational Development Support

Integrated PK/PD interpretation
Mechanistic validation
Biomarker-driven development strategies

Allumiqs Capabilities

Hallmarks of our multiomics solutions and capabilities

Comprehensive molecular profiling with proteomics, transcriptomics, metabolomics, and lipidomics
Flexible single-omics and integrated multiomics workflows
Biofluid and tissue analysis
Targeted LC‑MS/MS assays for PK/PD and biomarker follow‑up
Ultrasensitive protein profiling (e.g. NULISA™)
Cross‑platform data integration and interpretation

Connect with one of our multiomics experts to learn how we can help you go deeper than expression and understand impact.

Get Started Today